Signal active
Organization
Contact Information
Overview
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases. The company uses CRISPR technology that can subvert elements of the endogenous bacterial CRISPR machinery to eliminate hazardous bacteria in vivo, providing the health professionals with medicines that selectively target and kill bacteria with specific DNA sequences.
About
Biotechnology, Health Care, Biometrics
2017
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
SNIPR Biome headquartered in Europe, operates in the Biotechnology, Health Care, Biometrics sector. The company focuses on Biotechnology and has secured $3.8B in funding across 60 round(s). With a team of 11-50 employees, SNIPR Biome is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - SNIPR Biome, raised $3.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
1
0
$62.6M
Details
2
SNIPR Biome has raised a total of $62.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Early Stage Venture | 50.0M | ||
2017 | Seed | 3.2M |
Investors
SNIPR Biome is funded by 18 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
SNIPR Biome | - | FUNDING ROUND - SNIPR Biome | undefined |
Bill & Melinda Gates Foundation | - | FUNDING ROUND - Bill & Melinda Gates Foundation | undefined |
SNIPR Biome | - | FUNDING ROUND - SNIPR Biome | 3.2M |
Lundbeckfonden Emerge | - | FUNDING ROUND - Lundbeckfonden Emerge | 3.2M |
Recent Activity
There is no recent news or activity for this profile.